Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Cancer"
DOI: 10.1038/s41416-020-0948-x
Abstract: Three cardinal manifestations of neoplasia, namely inflammation, immune dysfunction, and coagulopathy are also seen in patients with severe SARS-CoV-2 infection, providing a biological rationale for testing selected anticancer drugs for their ability to control the… read more here.
Keywords: inflammation immune; anticancer drugs; immune dysfunction; dysfunction coagulopathy ... See more keywords